000 03698nam a22003615i 4500
001 277011
003 MX-SnUAN
005 20160429153800.0
007 cr nn 008mamaa
008 160108s2015 xxk| s |||| 0|eng d
020 _a9781447149873
_9978-1-4471-4987-3
035 _avtls000414505
039 9 _y201601081052
_zstaff
050 4 _aRC681-688.2
245 1 0 _aPatent foramen ovale /
_cedited by Zahid Amin, Jonathan M. Tobis, Horst Sievert, John D. Carroll.
264 1 _aLondon :
_bSpringer London :
_bSpringer,
_c2015.
300 _axiii, 243 páginas :
_b120 ilustraciones, 106 ilustraciones en color.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
500 _aSpringer eBooks
505 0 _aSECTION I: BACKGROUND AND ANATOMY -- Historical perspective and importance of PFO.- Embryology, Neonatal Circulation and Anatomy of PFO -- Anatomical variations of Patent Foramen Ovale -- Aging and Patent Foramen Ovale -- SECTION II: METHODS AND TECHNIQUES FOR DETECTION AND CHARACTERIZATION OF PFO -- Echocardiographic detection and transcranial Doppler quantification of right-to-left shunting -- ICE: intra-procedural evaluation and guidance during closure of PFO -- A Comparison of Methods to Detect and Quantitative PFO: TCD, TTE, ICE and TEE -- Angiographic evaluation for PFO and Pulmonary AVMs -- SECTION III: PFO AND CLINICAL SYNDROMES -- An Overview of Clinical Syndromes (Keeping The Heart In Mind) -- The Association of Patent Foramen Ovale and Migraine Headache -- Current Patient Management Issues, Clinical Trial Design Challenges and the Pathway Forward.- Patent foramen ovale and divers -- Orthodeoxia and Platypnea -- Obstructive Sleep Apnea and Patent Foramen Ovale -- PFO and Various Types of Surgery.- When a PFO is Discovered Incidentally -- SECTION IV: CLOSURE METHODS -- The GORE Septal Occluder -- The novel PFO specific closure devices: Why did they fail? -- Optimal device for children and closure indications in pediatric population -- Occlutech, PFM, Lifetech and other new devices. What’s on the horizon? -- Complications of PFO Closure -- SECTION V: STATISTICAL METHODS, TRIALS AND TRIBULATIONS -- Device Closure of Patent Foramen Ovale or Medical Therapy for Cryptogenic Stroke: The CLOSURE I Trial -- The Gore REDUCE Clinical Study -- The PC Trial: An Effective Treatment Not Demonstrating Effective Power -- From FDAs point of view: What is needed to move PFO closure for stroke prevention forward? -- The Medical Device Manufacturer’s Perspective – W.L. Gore & Associates, Inc -- PFO-Patient’s Perspective -- Clinical Trials to Assess the Relationship between Patent Foramen Ovale and Migraine Headaches -- Do We Need More PFO Trials: Hypercoaguable Syndromes, Obstructive Sleep Apnea, and Arrhythmias -- SECTION VI: DIFFICULTIES/OBSTACLES IN STARTING PFO CLOSURE PRACTICE -- Obstacles in Starting a PFO Closure Program. How I Did It -- Developing a successful integrated PFO closure program.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700 1 _aAmin, Zahid,
_eeditor.
_9299380
700 1 _aTobis, Jonathan M,
_eeditor.
_9299381
700 1 _aSievert, Horst,
_eeditor.
_9299382
700 1 _aCarroll, John D,
_eeditor.
_9299383
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9781447149866
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-1-4471-4987-3
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c277011
_d277011